Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Trial Type:  Supportive care
Treatment/Intervention:  supportive care
Results 1-25 of 405 for your search:
Start Over
Interpersonal Therapy for Depression in Breast Cancer
Phase: Phase IV
Type: Behavioral study, Supportive care
Age: 18 to 90
Trial IDs: #5996/7033R, NCI-2014-02374, #5996, NCT01191580
A Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide
Phase: Phase IV
Type: Supportive care
Age: Not specified
Trial IDs: 9785-CL-0403, NCI-2014-01193, 2013-003022-92, U1111-1157-0224, NCT01977651
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
Phase: Phase IV
Type: Supportive care
Age: 18 and over
Trial IDs: NEO09-100, NCI-2012-02974, NCT01394978
Perampanel in Lowering the Incidence of Seizures in Patients with Primary Glioma
Phase: Phase IV
Type: Supportive care
Age: 18 and over
Trial IDs: Pro00055609, NCI-2015-00365, NCT02363933
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
Phase: Phase III, Phase II
Type: Supportive care
Age: 18 months to 21 years
Trial IDs: #1R01FD003410-01, NCI-2014-01209, R01 FD003410-01-A1, NCT00999713
Eltrombopag Olamine in Treating Thrombocytopenia in Patients with Chronic Myeloid Leukemia or Myelofibrosis Receiving Tyrosine Kinase Therapy
Phase: Phase III, Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: 2011-0319, NCI-2011-03336, NCT01428635
Atorvastatin Calcium in Preventing Cardiovascular Complications in Patients with Newly Diagnosed Stage I-III Breast Cancer or Lymphoma Undergoing Anthracycline-Based Chemotherapy
Phase: Phase III, Phase II
Type: Supportive care
Age: 30 to 80
Trial IDs: 98213, NCI-2013-01760, 00024197, CCCWFU 98213, WF 98213, WFU 98213, NCT01988571
Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma
Phase: Phase III
Type: Supportive care, Treatment
Age: 3 to 21 at diagnosis
Trial IDs: ACNS0331, NCI-2009-00335, CDR0000365506, COG-ACNS0331, NCT00085735
Radiation Therapy with or without Temozolomide in Treating Patients with Anaplastic Glioma
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Age: 18 and over
Trial IDs: RTOG 0834, NCI-2011-02070, CAN-NCIC-CEC1, CDR0000582632, COGNO-EORTC-26053, EORTC-22054, EORTC-26053, EUDRACT-2006-001533-17, MERCK-EORTC-26053, MRC-BR14, SPRI-EORTC-26053, CEC1, NCT00626990
Combination Chemotherapy and Surgery in Treating Young Patients with Wilms Tumor
Phase: Phase III
Type: Supportive care, Treatment
Age: Under 30 at initial diagnosis
Trial IDs: AREN0534, NCI-2011-01953, CDR0000649716, COG-AREN0534, NCT00945009
Radiation Therapy with or without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
Phase: Phase III
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: RTOG 0920, NCI-2011-00878, CDR0000651536, NCT01311063, NCT00956007
Treating Mild or Moderate Lymphedema in Women Who Have Undergone Treatment for Breast Cancer
Phase: Phase III
Type: Supportive care
Age: 18 and over
Trial IDs: 08-308, NCI-2009-01263, NCT00959985
Radiation Therapy with or without Temozolomide in Treating Patients with Low-Grade Glioma
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Age: 18 and over
Trial IDs: E3F05, NCI-2011-01971, CDR0000654697, ECOG-E3F05, NCT00978458
Chemotherapy and Pelvic Radiation Therapy with or without Additional Chemotherapy in Treating Patients with High-Risk Early-Stage Cervical Cancer after Radical Hysterectomy
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Age: 18 and over
Trial IDs: RTOG 0724/GOG-0724, NCI-2011-01973, CDR0000654709, GOG-0724, RTOG-0724, NCT00980954
Acupuncture in Treating Dry Mouth Caused by Radiation Therapy in Patients with Head and Neck Cancer
Phase: Phase III
Type: Supportive care
Age: Not specified
Trial IDs: 97115, NCI-2011-02073, CDR0000674208, WF 97115, WFU-97115, MDA-04-01, NCT01141231
Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia
Phase: Phase III
Type: Supportive care, Treatment
Age: 1 to < 10
Trial IDs: AALL0932, NCI-2011-02599, CDR0000683227, COG-AALL0932, NCT01190930
Yoga or Stretching and Relaxation in Improving Physical Function in Patients with Stage 0-III Breast Cancer Undergoing Radiation Therapy
Phase: Phase III
Type: Supportive care
Age: 18 and over
Trial IDs: 2009-0976, NCI-2012-01895, NCT01202851
Gabapentin in Treating Patients With Pain After Surgery
Phase: Phase III
Type: Supportive care
Age: 18 to 75
Trial IDs: VAR0054, NCI-2011-00010, NCT01067144
Graft-Versus-Host Disease Prophylaxis in Treating Patients with Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Age: not specified
Trial IDs: 2448.00, NCI-2010-02035, NCT01231412
Acupuncture in Preventing Radiation-Induced Xerostomia
Phase: Phase III
Type: Supportive care
Age: 18 and over
Trial IDs: 2010-0584, NCI-2011-00306, NCT01266044
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
Phase: Phase III
Type: Supportive care
Age: 6 months to 21 years
Trial IDs: ACCL0934, NCI-2011-02636, CDR0000695661, COG-ACCL0934, NCT01371656
Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients with Acute Myeloid Leukemia Who Are Undergoing Chemotherapy
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Age: 3 months to 30 years
Trial IDs: ACCL0933, NCI-2011-02640, CDR0000695748, COG-ACCL0933, NCT01307579
Acupressure in Controlling Nausea in Young Patients with Central Nervous System or Solid Tumors Receiving Nausea-Inducing Chemotherapy
Phase: Phase III
Type: Supportive care
Age: 4 to 18
Trial IDs: SCUSF 1202, NCI-2011-02668, ACCL1032, CDR0000699766, COG-ACCL1032, NCT01346267
Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer
Phase: Phase III
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: ANZGOG-0902/GOG-0274/RTOG-1174, NCI-2011-02978, ANZGOG-0902, CDR0000706698, GOG-0274, RTOG-1174, ANZGOG-0902-GOG-0274, NCT01414608
Start Over